Macular Degeneration Exudative Eye Left Clinical Trial
— QUAOBAREOfficial title:
OCTA Versus Structural OCT: Quantitative OCTA Biomarkers of Remission in Neovascular AMD
| Verified date | July 2020 |
| Source | Centre Hospitalier Intercommunal Creteil |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The objective is to find if there is a relationship between the Fractal Dimension, the gap, vascular density (VD), the surface, the span ratio and the status of the choroidal neovessels to adjust the interval between 2 intravitreal injections nor on the qualitative aspect of Optical Coherence Structural Tomography but also on quantified quantitative and objective values.
| Status | Completed |
| Enrollment | 130 |
| Est. completion date | July 1, 2020 |
| Est. primary completion date | July 1, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 50 Years and older |
| Eligibility |
Inclusion Criteria: - Man / woman over 50, - Showing type 1 or type 2 CNV (choroidal neovessel) related to AMD during the second year of follow-up. - Acceptance to participate in the protocol - Affiliated to a social security scheme Exclusion Criteria: - Type III CNV related to AMD, - Other cause of CNV - Signal less than 80 decibel and detachment of pigment epithelium (PED) greater than 250 µm on structural OCT B. - Protected Majors (Guardianship, Curator, Safeguard of Justice) - Participation in another interventional research. - Refusal to participate in the study |
| Country | Name | City | State |
|---|---|---|---|
| France | CHI Créteil | Créteil | |
| France | Centre Bergouignan | Évreux | |
| France | Centre d'exploration ophtalmologique de l'odéon | Paris |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier Intercommunal Creteil |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Fractal dimension (without unit) | Analysis of fractal dimension measured on OCT-A (Angiography Optical Coherence Tomography ) on 4 consecutive examinations. | 12 months | |
| Primary | Fractal lacunarity (without unit) | Analysis of lacunarity measured by OCT-A on 4 consecutive examinations. | 12 months | |
| Primary | Vascular density (%) | Analysis of vascular density measured by OCT-A on 4 consecutive examinations. | 12 months | |
| Primary | Vascular surface (micronm2) | Analysis of vascular surface measured by OCT-A on 4 consecutive examinations. | 12 months | |
| Secondary | Relationship between fractal dimension measured by OCT-A and choroidal neovascular (CNV) status | Investigation of a relationship between fractal dimension mesured on OCT-A and the status of choroidal neovessels | 12 months | |
| Secondary | Relationship between fractal lacunarity measured by OCT-A and choroidal neovascular (CNV) status | Investigation of a relationship between fractal lacunarity and the status of choroidal neovessels | 12 months | |
| Secondary | Relationship between vascular density measured by OCT-A and choroidal neovascular (CNV) status | Investigation of a relationship between vascula density and the status of choroidal neovessels | 12 months | |
| Secondary | Relationship between vascular surface measured by OCT-A and choroidal neovascular (CNV) status | Investigation of a relationship between vascular surface and the status of choroidal neovessels | 12 months |